Sharon Liu’s practice focuses on the formation and operation of investment funds and related matters.

Sharon advises fund managers on fund formation and institutional investors on investments in a range of private funds, including private equity funds, hedge funds, real estate funds, co-investment vehicles, and separately managed accounts. She also has experience advising sovereign wealth funds, insurance companies, and other institutional investors on fund investments and related due diligence, documentation, and post-closing matters.

In addition, she has experience advising on secondary transactions and fund-related regulatory and compliance matters in Hong Kong and the United States.

Prior to joining MoFo, Sharon worked in the funds and asset management team at another leading international law firm in Hong Kong.

Sharon is a Registered Foreign Lawyer with the Law Society of Hong Kong. Sharon is fluent in English and Mandarin.

Representative Experience

LP Representations

• A major Asian sovereign wealth fund in its participation in venture capital funds sponsored by a leading U.S.-based investment firm for investments in a leading artificial intelligence company.
• A large insurance company in the formation of a separately managed account managed by a leading global private equity asset manager.
• A consortium of development finance institutions in the initial closing of a pan-African growth equity fund that invests in education, healthcare, financial services, and consumer goods sectors.

GP Representations

• A leading Asian wealth and asset management company in the establishment of private equity funds and open-ended real estate funds.
• A China-based venture capital firm in the formation of a venture capital fund focused on early- and growth-stage investments in the TMT sector in China.
• An Abu Dhabi-based global investment firm and a Hong Kong-based investment platform in the formation of a co-GP sponsored private equity fund.
• A healthcare-focused private equity firm in the formation and first and second closings of a US$935 million fund focused on investing in the healthcare sector across the U.S. and Asia.
• A leading Asia-focused healthcare asset management firm in the formation of a US$1.67 billion healthcare buyout and growth fund focused on China and the broader Asia-Pacific region.
• An Asia-focused private equity firm in the formation of a growth equity fund investing in Asia with a focus on healthcare and consumer and business products and services.
• A leading Asian venture capital firm in the formation of a US$390 million China-focused venture capital fund investing primarily in early-stage technology companies.